Board of Directors
Roger Howe, Ph.D.
Executive Chairman, Stemedica Cell Technologies Inc.
free online math tutoring viagra derivatives urine r cialis cipro nsaid https://www.flseagrant.org/news/buy-essay-now/29/ mens sexual health viagra phaloplasty sildenafil efectos secundarios en jovenes https://fall.law.fsu.edu/crc/?med=free-trial-offer-for-viagra thesis defense session http://tofinoseakayaking.com/dream-essay-examples-596/ que es viagra en espaГ±ol viagra neuro research get link click writing service cheap everyday cialis best place to buy viagra professional xenical without prescription au science assignment help click here follow link enter site go to site https://lolindasf.com/library/custom-dissertations/62/ go here cialis and fainting propranolol oral custom writing sign up https://roanokechowan.edu/pharmacy/nascar-driver-viagra-appeared/21/ viagra side effects tingling Dr. Roger Howe is the executive chairman of Stemedica Cell Technologies Inc., Stemedica International’s parent company. His 43-year career spans leadership positions at several successful biotech and IT startups, including Cardiovascular Systems (NASDAQ:CSII), National Information Systems Inc., Metrix Communications and Reliant Technologies, which developed Fraxel, a revolutionary, FDA-approved medical laser for skin surgery (now Valeant Pharmaceuticals International Inc. NYSE: VRX). In addition to several published articles, he has written and co-written several books: “Quality on Trial,” “Customer Relationship Management” and “Miracle of Stem Cells: How Adult Stem Cells are Transforming Medicine.” He earned his Ph.D. in communications from Kent State University, his M.S. in sociology from the University of Minnesota and his B.S. in English from Wisconsin State University. In the nonprofit sector he passionately supports the Boundary Waters Experience, which provides young people with wilderness experiences.